NPI: 1124053210 · ALBUQUERQUE, NM 87106 · Family Medicine Physician · NPI assigned 07/11/2006
Authorized official CASTILLO, EMILY controls 20+ related entities in our dataset. Read more
| Authorized Official | CASTILLO, EMILY (ASSOCIATE DIRECTOR) |
| NPI Enumeration Date | 07/11/2006 |
Other providers sharing the same authorized official: CASTILLO, EMILY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 76,238 | $3.95M |
| 2019 | 79,575 | $4.43M |
| 2020 | 48,968 | $2.63M |
| 2021 | 61,832 | $3.33M |
| 2022 | 60,407 | $3.48M |
| 2023 | 58,732 | $3.67M |
| 2024 | 24,809 | $2.15M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 78,783 | 74,572 | $6.47M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 58,195 | 55,148 | $4.04M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 33,006 | 32,739 | $1.72M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 13,372 | 13,306 | $1.54M |
| 90461 | 17,117 | 16,996 | $1.46M | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 12,113 | 12,061 | $1.40M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11,057 | 10,292 | $1.25M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 8,084 | 8,043 | $928K |
| 99173 | 19,780 | 19,682 | $759K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 24,487 | 24,307 | $428K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 149 | 135 | $269K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,159 | 1,953 | $205K |
| 99215 | Prolong outpt/office vis | 2,170 | 2,051 | $199K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 259 | 243 | $182K |
| 90677 | 573 | 565 | $169K | |
| 20610 | 3,316 | 2,591 | $136K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,396 | 1,363 | $119K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 5,037 | 5,006 | $115K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,399 | 2,337 | $109K |
| 62323 | 1,026 | 984 | $107K | |
| 99177 | 3,097 | 3,087 | $106K | |
| 95913 | 521 | 493 | $94K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,791 | 1,768 | $82K |
| 76000 | 2,530 | 2,249 | $79K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1,228 | 1,190 | $69K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 497 | 464 | $69K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,838 | 3,795 | $67K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 469 | 456 | $61K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 628 | 596 | $55K |
| 95886 | 545 | 516 | $53K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,855 | 1,652 | $53K |
| 92551 | 4,295 | 4,253 | $51K | |
| J0178 | Injection, aflibercept, 1 mg | 96 | 76 | $50K |
| 73564 | 2,153 | 1,957 | $48K | |
| 99188 | 2,541 | 2,525 | $48K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 418 | 411 | $41K |
| 96127 | 6,782 | 6,732 | $38K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,890 | 1,603 | $38K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 673 | 665 | $35K |
| 76830 | Ultrasound, transvaginal | 622 | 614 | $33K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,110 | 873 | $30K |
| 90674 | 1,093 | 1,083 | $26K | |
| 99381 | 143 | 137 | $26K | |
| 71046 | Radiologic examination, chest; 2 views | 1,636 | 1,506 | $24K |
| 73630 | 1,267 | 1,134 | $24K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 615 | 470 | $23K |
| 76942 | 781 | 747 | $23K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 358 | 354 | $23K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 216 | 209 | $23K |
| 73030 | 1,593 | 1,453 | $22K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 465 | 453 | $22K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 365 | 358 | $21K |
| 20550 | 400 | 372 | $21K | |
| 64615 | 249 | 244 | $20K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 270 | 261 | $17K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 2,241 | 2,162 | $16K |
| 90756 | 624 | 622 | $16K | |
| 73221 | 124 | 117 | $15K | |
| 92134 | 883 | 775 | $15K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,319 | 1,223 | $14K |
| 31231 | 100 | 95 | $14K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 723 | 687 | $14K |
| 99383 | 68 | 68 | $13K | |
| 0012A | 366 | 362 | $13K | |
| 73130 | 739 | 650 | $13K | |
| 73610 | 729 | 658 | $13K | |
| 73110 | 720 | 641 | $12K | |
| 90671 | 43 | 43 | $12K | |
| 64493 | 81 | 79 | $12K | |
| 90619 | 88 | 87 | $12K | |
| 73502 | 537 | 523 | $10K | |
| 62321 | 88 | 77 | $10K | |
| 72141 | 96 | 93 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 529 | 500 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 160 | 159 | $9K |
| 97802 | 190 | 188 | $9K | |
| 93000 | 1,132 | 1,088 | $8K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 1,118 | 1,069 | $8K |
| 76536 | 196 | 193 | $8K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 51 | 50 | $7K |
| 81025 | 935 | 897 | $7K | |
| 72110 | 286 | 281 | $7K | |
| 76642 | 116 | 113 | $7K | |
| 93970 | 58 | 56 | $7K | |
| 99441 | 299 | 276 | $7K | |
| 90734 | 1,990 | 1,977 | $7K | |
| 94060 | 261 | 242 | $6K | |
| 93793 | 894 | 592 | $6K | |
| 90651 | 2,998 | 2,970 | $6K | |
| 97803 | 211 | 193 | $6K | |
| 20553 | 171 | 161 | $6K | |
| 90698 | 6,428 | 6,381 | $6K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 30 | 28 | $6K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 127 | 115 | $6K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 12 | 12 | $6K |
| 93971 | 65 | 63 | $5K | |
| 99384 | 26 | 26 | $5K | |
| 99051 | 572 | 560 | $4K | |
| 94729 | 188 | 173 | $4K | |
| 64494 | 62 | 60 | $4K | |
| 92557 | 176 | 171 | $4K | |
| 0011A | 208 | 206 | $4K | |
| 71250 | 68 | 64 | $4K | |
| 99201 | 99 | 95 | $4K | |
| 96161 | 774 | 723 | $4K | |
| 73080 | 210 | 187 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 39 | 39 | $3K |
| 90473 | 144 | 143 | $3K | |
| 99205 | Prolong outpt/office vis | 16 | 16 | $3K |
| 94726 | 127 | 123 | $3K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 84 | 83 | $3K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 13 | 13 | $3K |
| 72050 | 148 | 145 | $3K | |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 23 | 12 | $3K |
| 98966 | 309 | 203 | $3K | |
| 74018 | 153 | 118 | $3K | |
| 92567 | 278 | 269 | $3K | |
| 77080 | 108 | 105 | $2K | |
| 99443 | 38 | 34 | $2K | |
| 72120 | 110 | 108 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 28 | 28 | $2K |
| 90710 | 430 | 426 | $2K | |
| 87807 | 126 | 124 | $2K | |
| 10060 | 53 | 50 | $2K | |
| 20552 | 46 | 45 | $2K | |
| J2785 | Injection, regadenoson, 0.1 mg | 17 | 16 | $2K |
| 90686 | 11,087 | 11,036 | $2K | |
| 73562 | 79 | 69 | $2K | |
| 90680 | 3,279 | 3,241 | $2K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 14 | 13 | $2K |
| 72100 | 95 | 92 | $2K | |
| 77066 | Tomosynthesis, mammo | 12 | 12 | $2K |
| 0111A | 35 | 35 | $1K | |
| 99442 | 27 | 26 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 158 | 153 | $1K |
| 85610 | 327 | 233 | $1K | |
| 90633 | 2,734 | 2,722 | $1K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 75 | 60 | $1K |
| 92015 | Determination of refractive state | 212 | 206 | $1K |
| 73140 | 79 | 72 | $1K | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 30 | 27 | $1K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 53 | 52 | $1K |
| 90661 | 41 | 40 | $1K | |
| 99221 | 13 | 13 | $1K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 47 | 27 | $1K |
| 90620 | 115 | 115 | $973.82 | |
| 77071 | 47 | 43 | $971.38 | |
| 90474 | 34 | 34 | $832.82 | |
| 90696 | 404 | 400 | $621.61 | |
| 90744 | 1,392 | 1,377 | $620.45 | |
| D1206 | Topical application of fluoride varnish | 42 | 42 | $603.00 |
| 90715 | 644 | 633 | $526.45 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 33 | 30 | $331.02 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 14 | 13 | $309.89 |
| G0008 | Administration of influenza virus vaccine | 29 | 29 | $295.23 |
| 17000 | 13 | 12 | $290.73 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 37 | 37 | $255.48 |
| 76857 | 14 | 13 | $254.59 | |
| 90670 | 6,432 | 6,386 | $220.49 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 610 | 592 | $217.82 |
| 90707 | 176 | 176 | $169.25 | |
| 73560 | 12 | 12 | $159.11 | |
| 72040 | 12 | 12 | $145.09 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 63 | 56 | $107.83 |
| J3411 | Injection, thiamine hcl, 100 mg | 29 | 25 | $101.80 |
| 90716 | 176 | 176 | $100.56 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 254 | 242 | $71.05 |
| 94760 | 371 | 359 | $69.18 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 38 | 37 | $55.19 |
| 81003 | 16 | 13 | $20.91 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 18 | 14 | $0.77 |
| 91301 | 121 | 121 | $0.58 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 53 | 50 | $0.15 |
| 91311 | 65 | 65 | $0.14 | |
| 90672 | 361 | 360 | $0.01 | |
| 3078F | 989 | 918 | $0.00 | |
| 1160F | 752 | 689 | $0.00 | |
| 90685 | 834 | 832 | $0.00 | |
| 90621 | 88 | 88 | $0.00 | |
| 1159F | 630 | 582 | $0.00 | |
| 3077F | 47 | 46 | $0.00 | |
| 90648 | 66 | 66 | $0.00 | |
| 3079F | 420 | 400 | $0.00 | |
| 3074F | 368 | 352 | $0.00 | |
| 3073F | 888 | 823 | $0.00 | |
| 1125F | 421 | 382 | $0.00 | |
| 3008F | 249 | 243 | $0.00 | |
| 1126F | 457 | 427 | $0.00 | |
| 3075F | 98 | 97 | $0.00 | |
| 90723 | 134 | 134 | $0.00 | |
| 3080F | 44 | 44 | $0.00 | |
| 90656 | 19 | 19 | $0.00 | |
| 90647 | 28 | 28 | $0.00 |